
Joshua Delbert Mitchell MD MSCI, FACC, FICOS
Echocardiography, Non-Invasive Cardiology, Preventive Cardiology, Clinical Informatics
Director, Cardio-Oncology Center of Excellence; Co-Director, Amyloid Center of Excellence, Washington University in St. Louis
Join to View Full Profile
1 Barnes Jewish Hospital Plz# DivSaint Louis, MO 63110
Phone+1 314-362-1291
Fax+1 314-362-1417
Dr. Mitchell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Joshua Mitchell, MD, MSCI is an Associate Professor of Medicine, Director of the Cardio-Oncology Center of Excellence, Director of the Cardio-Oncology Fellowship, and Co-Director of the Amyloid Center of Excellence, Washington University School of Medicine in St. Louis. Prior to moving to Washington University in 2015, he served 11 years in the Army, both as a Field Artillery Officer and as a physician, serving with the 82nd Airborne Division and the 75th Ranger Regiment. During his service, he reached the rank of Major and was awarded two Bronze Star Medals. In addition to his Washington University duties, he serves on the JACC:Cardio-Oncology and American Journal of Medicine editorial boards, chairs the ICOS Patient Advocacy working group, and is a member of the ICOS Scientific Committee, previously chairing the 2021 ICOS expert consensus statement for cardiovascular disease screening in radiation survivors. His clinical and research interests include better characterizing and understanding cardiovascular disease associated with cancer treatment, and the diagnosis of management of cardiac amyloidosis. His research has also focused on the use of coronary artery calcium to improve risk prediction and help target preventive therapy.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardio-Oncology and Amyloidosis, 2017 - 2018
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2015 - 2018
- National Capital ConsortiumResidency, Internal Medicine, 2008 - 2011
- University of Texas Southwestern Medical SchoolClass of 2008
Certifications & Licensure
- IL State Medical License 2020 - 2026
- MO State Medical License 2015 - 2026
- PA State Medical License 2017 - 2018
- GA State Medical License 2012 - 2015
- VA State Medical License 2009 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Continuous Versus Intermittent cARdiac Electrical moNitorinG Start of enrollment: 2023 Nov 21
Roles: Contact, Principal Investigator
- Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure Start of enrollment: 2019 Aug 21
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- ASO Author Reflections: Plasma Ceramide Levels Aid in Prognosis in Pancreatic Ductal Adenocarcinoma.Joshua D Mitchell, Linda R Peterson
Annals of Surgical Oncology. 2025-04-04 - Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020.Nischit Baral, Elena Deych, Deepak Chandramohan, Arvind Kunadi, Tarec K Elajami
Cancer Epidemiology. 2025-04-01 - Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications.Maximilian Leo Müller, Anna Brand, Isabel Mattig, Sebastian Spethmann, Daniel Messroghli
Circulation. Heart Failure. 2025-02-01
Authored Content
- Practical Integration of the ASCO Guidelines for Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers12/4/2018
- Management of Cancer-Therapy-Induced LV Dysfunction: Can the Guidelines Help?10/30/2018
Press Mentions
- BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-Type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific SessionsMarch 24th, 2025
- Cardio-Oncology Topics from ACC.20/WCC VirtualJune 5th, 2020
- Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study ShowsNovember 6th, 2018
Professional Memberships
- Fellow
- Member
- Member
- Member
- International Cardio-Oncology SocietyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: